358 related articles for article (PubMed ID: 23287562)
1. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
2. C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.
Maeda Y; Kawano Y; Wada Y; Yatsuda J; Motoshima T; Murakami Y; Kikuchi K; Imamura T; Eto M
Oncol Rep; 2015 Apr; 33(4):1844-50. PubMed ID: 25682807
[TBL] [Abstract][Full Text] [Related]
3. C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.
Kaida T; Nitta H; Kitano Y; Yamamura K; Arima K; Izumi D; Higashi T; Kurashige J; Imai K; Hayashi H; Iwatsuki M; Ishimoto T; Hashimoto D; Yamashita Y; Chikamoto A; Imanura T; Ishiko T; Beppu T; Baba H
Oncotarget; 2016 Dec; 7(51):84798-84809. PubMed ID: 27756879
[TBL] [Abstract][Full Text] [Related]
4. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness.
Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T
Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844
[TBL] [Abstract][Full Text] [Related]
5. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
Imamura R; Kitagawa S; Kubo T; Irie A; Kariu T; Yoneda M; Kamba T; Imamura T
Prostate; 2021 Feb; 81(3):147-156. PubMed ID: 33368414
[TBL] [Abstract][Full Text] [Related]
7. Pulp progenitor cell recruitment is selectively guided by a C5a gradient.
Chmilewsky F; Jeanneau C; Laurent P; Kirschfink M; About I
J Dent Res; 2013 Jun; 92(6):532-9. PubMed ID: 23603337
[TBL] [Abstract][Full Text] [Related]
8. Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.
Imamura T; Yamamoto-Ibusuki M; Sueta A; Kubo T; Irie A; Kikuchi K; Kariu T; Iwase H
Breast Cancer; 2016 Nov; 23(6):876-885. PubMed ID: 26494574
[TBL] [Abstract][Full Text] [Related]
9. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
10. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
[TBL] [Abstract][Full Text] [Related]
11. PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR/C5a axis from the tumor microenvironment.
Saito K; Iioka H; Maruyama S; Sumardika IW; Sakaguchi M; Kondo E
Neoplasia; 2019 Dec; 21(12):1121-1132. PubMed ID: 31759250
[TBL] [Abstract][Full Text] [Related]
12. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
[TBL] [Abstract][Full Text] [Related]
13. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.
Speidl WS; Kastl SP; Hutter R; Katsaros KM; Kaun C; Bauriedel G; Maurer G; Huber K; Badimon JJ; Wojta J
FASEB J; 2011 Jan; 25(1):35-44. PubMed ID: 20813982
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
[TBL] [Abstract][Full Text] [Related]
16. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
[TBL] [Abstract][Full Text] [Related]
17. Functional identification of the stable transfection C5aR cell line Molt-4.
Zhang C; Xu R; Wang J; Han G; Chen G; Wang R; Wei H; Shen B; Ma Y; Li Y
Cell Mol Immunol; 2007 Dec; 4(6):461-5. PubMed ID: 18163958
[TBL] [Abstract][Full Text] [Related]
18. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
[TBL] [Abstract][Full Text] [Related]
19. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
Chen J; Sun ZH; Chen LY; Xu F; Zhao YP; Li GQ; Tang M; Li Y; Zheng QY; Wang SF; Yang XH; Wu YZ; Xu GL
Aging (Albany NY); 2020 Jul; 12(14):14285-14299. PubMed ID: 32669478
[TBL] [Abstract][Full Text] [Related]
20. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
